Treeline Biosciences

News

Recent biotech financings include a $200m round for Treeline, with Enveda, Wugen, CHARM Therapeutics, and MRM Health also in on the action.

News

AstraZeneca has high sales expectations for HPP therapy efzimfotase alfa, but will the data support the broad label needed to unlock its potential?

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.